These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 31351965)

  • 1. Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study.
    Krupka E; Jiang GL; Jan C
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1599-1607. PubMed ID: 31351965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial.
    Watt FE; Blauwet MB; Fakhoury A; Jacobs H; Smulders R; Lane NE
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1590-1598. PubMed ID: 31356878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial.
    Petterson SC; Plancher KD
    Knee Surg Sports Traumatol Arthrosc; 2019 Jun; 27(6):1992-2002. PubMed ID: 30159738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee.
    Petrella RJ; Petrella M
    J Rheumatol; 2006 May; 33(5):951-6. PubMed ID: 16652426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline.
    Brander V; Skrepnik N; Petrella RJ; Jiang GL; Accomando B; Vardanyan A
    Osteoarthritis Cartilage; 2019 Jan; 27(1):59-70. PubMed ID: 30223023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
    Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee.
    Strand V; Baraf HSB; Lavin PT; Lim S; Hosokawa H
    Osteoarthritis Cartilage; 2012 May; 20(5):350-356. PubMed ID: 22342928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
    Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
    Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.
    Langworthy MJ; Conaghan PG; Ruane JJ; Kivitz AJ; Lufkin J; Cinar A; Kelley SD
    Adv Ther; 2019 Jun; 36(6):1398-1411. PubMed ID: 30968336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial.
    Kon E; Engebretsen L; Verdonk P; Nehrer S; Filardo G
    Am J Sports Med; 2018 Jan; 46(1):171-180. PubMed ID: 29016185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study.
    McAlindon TE; Schmidt U; Bugarin D; Abrams S; Geib T; DeGryse RE; Kim K; Schnitzer TJ
    Osteoarthritis Cartilage; 2018 Oct; 26(10):1291-1299. PubMed ID: 29753118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a single intra-articular injection of 6 ml Hylan G-F 20 compared to placebo in Chinese patients with symptomatic knee osteoarthritis : C-SOUND study, a 26-week multicenter double-blind randomized placebo-controlled trial in China.
    Ke Y; Jiang W; Xu Y; Chen Y; Zhang Q; Xue Q; Lin J; Ngai W; Nian G; Fazeli MS; Xie Y; Zhu Z
    BMC Musculoskelet Disord; 2021 May; 22(1):428. PubMed ID: 33964907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety.
    Sun SF; Hsu CW; Lin HS; Liou IH; Chen YH; Hung CL
    J Bone Joint Surg Am; 2017 Mar; 99(6):462-471. PubMed ID: 28291178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.
    Chevalier X; Jerosch J; Goupille P; van Dijk N; Luyten FP; Scott DL; Bailleul F; Pavelka K
    Ann Rheum Dis; 2010 Jan; 69(1):113-9. PubMed ID: 19304567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis.
    Conrozier T; Eymard F; Chouk M; Chevalier X
    BMC Musculoskelet Disord; 2019 Aug; 20(1):376. PubMed ID: 31421686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial.
    Petrella RJ; DiSilvestro MD; Hildebrand C
    Arch Intern Med; 2002 Feb; 162(3):292-8. PubMed ID: 11822921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.
    Yazici Y; McAlindon TE; Fleischmann R; Gibofsky A; Lane NE; Kivitz AJ; Skrepnik N; Armas E; Swearingen CJ; DiFrancesco A; Tambiah JRS; Hood J; Hochberg MC
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1598-1606. PubMed ID: 28711582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.
    Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Clauw D; Jones M; Bergfeld J; Swearingen CJ; DiFrancesco A; Simsek I; Tambiah J; Hochberg MC
    Arthritis Rheumatol; 2020 Oct; 72(10):1694-1706. PubMed ID: 32432388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary Trial of Intra-articular LMWF-5A for Osteoarthritis of the Knee.
    Schwappach J; Dryden SM; Salottolo KM
    Orthopedics; 2017 Jan; 40(1):e49-e53. PubMed ID: 27684085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study.
    Conaghan PG; Hunter DJ; Cohen SB; Kraus VB; Berenbaum F; Lieberman JR; Jones DG; Spitzer AI; Jevsevar DS; Katz NP; Burgess DJ; Lufkin J; Johnson JR; Bodick N;
    J Bone Joint Surg Am; 2018 Apr; 100(8):666-677. PubMed ID: 29664853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.